[1]
Lisan Shidqi, M.I., Santosa, B., Muslim, M. and Haitami, H. 2022. Evaluation in Hematology and BCR-ABL Molecular Profiles in Patients with Chronic Myeloid Leukemia Undergoing Tyrosine Kinase Inhibitor Therapy. Medical Laboratory Technology Journal. 8, 2 (Dec. 2022), 200–208. DOI:https://doi.org/10.31964/mltj.v8i1.484.